Monografie
Viral safety and evaluation of viral clearance from biopharmaceutical products : proceedings of a symposium, Natcher Conference Center, Bethesda, Maryland, USA, June 14 - 16, 1995 ; 73 tables
- Language
-
Deutsch
- Extent
-
X, 342 S.
- ISBN
-
978-3-8055-6391-8
- Identifier
-
949549908
- Series
-
Developments in biological standardization; Vol. 88
Subject
Pharmazeutische Technologie ; Gentechnologie ; Mikrobielle Kontamination ; Arzneimittelsicherheit ; Konferenzschrift Bethesda (Md.); Kongress Bethesda
Contributor
- Table of contents
- Rights
-
Der Zugriff auf Teile des Objekts ist unbeschränkt möglich.
- Last update
-
15.04.2024, 8:46 AM CEST
Object type
- Monografie
Associated
Other Objects (12)
Simian virus 40 (SV40) : a possible human polyomavirus ; Natcher Auditorium, NIH, Bethesda, Maryland, USA, January 27 and 28, 1997 ; proceedings of a workshop ; 39 tables
Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals : viral safety and regulatory aspects ; proceedings of a symposium, Strasbourg, France, May 5 - 6, 1998 ; 50 tables
International Symposium on Biological Product Freeze Drying and Formulation : proceedings of a symposium organized by the Center for Biologics Evaluation and Research of the United States Health Service Food and Drug Administration and the International Association of Biological Standardization, held at the Jack Masur Auditorium of the Warren Magnuson Clinical Center of the National Institutes of Health, Bethesda, Maryland, USA, 24 - 26 October 1990 ; 55 tables
Immunogenicity of therapeutic biological products : proceedings of a symposium ; National Institutes of Health, Bethesda, MD, USA, Oct. 31st - Nov. 2nd, 2001 ; 19 tables
Development of specifications for biotechnology pharmaceutical products : Hyatt Regency, San Francisco CA, USA, May 2 - 3, 1996 ; proceedings of a symposium ; 16 tables
Alternatives to animals in the development and control of biological products for human and veterinary use : proceedings of a symposium, London Zoo, London, UK, September 24 - 26, 1998 ; 41 tables
Genetic stability and recombinant product consistency : proceedings of a symposium ; Annecy, France, July 8 - 9, 1993 ; 28 tables
PDA EMEA European Virus Safety Forum : Paul-Ehrlich-Institut, Langen, Germany, September 29 - Oktober 1, 2003 ; proceedings of a conference ; 33 tables
A celebration of 50 years of progress in biological standardization and control at WHO : proceedings of a symposium, WHO Headquaters, Geneva, 25 - 27 October 1998 ; 26 tables
Characterization of biotechnology pharmaceutical products : proceedings of a symposium, Washington D.C., USA, December 11 - 13, 1995 ; 16 tables
Biological characterization and assay of cytokines and growth factors : proceedings of a symposium, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 10 - 12, 1997 ; 18 tables
State-of-the-art analytical methods for the characterization of biological products and assessment of comparability : proceedings of a conference, Natcher Building, National Institutes of Health (NIH) Bethesda, MD, USA, June 10 - 13, 2003 ; 32 tables
Simian virus 40 (SV40) : a possible human polyomavirus ; Natcher Auditorium, NIH, Bethesda, Maryland, USA, January 27 and 28, 1997 ; proceedings of a workshop ; 39 tables
Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals : viral safety and regulatory aspects ; proceedings of a symposium, Strasbourg, France, May 5 - 6, 1998 ; 50 tables
International Symposium on Biological Product Freeze Drying and Formulation : proceedings of a symposium organized by the Center for Biologics Evaluation and Research of the United States Health Service Food and Drug Administration and the International Association of Biological Standardization, held at the Jack Masur Auditorium of the Warren Magnuson Clinical Center of the National Institutes of Health, Bethesda, Maryland, USA, 24 - 26 October 1990 ; 55 tables
Immunogenicity of therapeutic biological products : proceedings of a symposium ; National Institutes of Health, Bethesda, MD, USA, Oct. 31st - Nov. 2nd, 2001 ; 19 tables
Development of specifications for biotechnology pharmaceutical products : Hyatt Regency, San Francisco CA, USA, May 2 - 3, 1996 ; proceedings of a symposium ; 16 tables
Alternatives to animals in the development and control of biological products for human and veterinary use : proceedings of a symposium, London Zoo, London, UK, September 24 - 26, 1998 ; 41 tables
Genetic stability and recombinant product consistency : proceedings of a symposium ; Annecy, France, July 8 - 9, 1993 ; 28 tables
PDA EMEA European Virus Safety Forum : Paul-Ehrlich-Institut, Langen, Germany, September 29 - Oktober 1, 2003 ; proceedings of a conference ; 33 tables
A celebration of 50 years of progress in biological standardization and control at WHO : proceedings of a symposium, WHO Headquaters, Geneva, 25 - 27 October 1998 ; 26 tables
Characterization of biotechnology pharmaceutical products : proceedings of a symposium, Washington D.C., USA, December 11 - 13, 1995 ; 16 tables
Biological characterization and assay of cytokines and growth factors : proceedings of a symposium, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 10 - 12, 1997 ; 18 tables
State-of-the-art analytical methods for the characterization of biological products and assessment of comparability : proceedings of a conference, Natcher Building, National Institutes of Health (NIH) Bethesda, MD, USA, June 10 - 13, 2003 ; 32 tables
Simian virus 40 (SV40) : a possible human polyomavirus ; Natcher Auditorium, NIH, Bethesda, Maryland, USA, January 27 and 28, 1997 ; proceedings of a workshop ; 39 tables
Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals : viral safety and regulatory aspects ; proceedings of a symposium, Strasbourg, France, May 5 - 6, 1998 ; 50 tables
International Symposium on Biological Product Freeze Drying and Formulation : proceedings of a symposium organized by the Center for Biologics Evaluation and Research of the United States Health Service Food and Drug Administration and the International Association of Biological Standardization, held at the Jack Masur Auditorium of the Warren Magnuson Clinical Center of the National Institutes of Health, Bethesda, Maryland, USA, 24 - 26 October 1990 ; 55 tables
Immunogenicity of therapeutic biological products : proceedings of a symposium ; National Institutes of Health, Bethesda, MD, USA, Oct. 31st - Nov. 2nd, 2001 ; 19 tables
Development of specifications for biotechnology pharmaceutical products : Hyatt Regency, San Francisco CA, USA, May 2 - 3, 1996 ; proceedings of a symposium ; 16 tables
Alternatives to animals in the development and control of biological products for human and veterinary use : proceedings of a symposium, London Zoo, London, UK, September 24 - 26, 1998 ; 41 tables
Genetic stability and recombinant product consistency : proceedings of a symposium ; Annecy, France, July 8 - 9, 1993 ; 28 tables
PDA EMEA European Virus Safety Forum : Paul-Ehrlich-Institut, Langen, Germany, September 29 - Oktober 1, 2003 ; proceedings of a conference ; 33 tables
A celebration of 50 years of progress in biological standardization and control at WHO : proceedings of a symposium, WHO Headquaters, Geneva, 25 - 27 October 1998 ; 26 tables
Characterization of biotechnology pharmaceutical products : proceedings of a symposium, Washington D.C., USA, December 11 - 13, 1995 ; 16 tables
Biological characterization and assay of cytokines and growth factors : proceedings of a symposium, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 10 - 12, 1997 ; 18 tables